• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: AD

Depression correlated with Lewy bodies, neuronal loss

March 30, 2011  

White matter hyperintensities predict cognitive decline

February 23, 2011  

Negative trial of DHA supplementation in Alzheimer’s disease

January 26, 2011  

Saliva amyloid proposed as Alzheimer disease biomarker

January 12, 2011  

Risperidone, citalopram: little benefit in dementia with Lewy bodies

November 10, 2010  

Effect of donepezil on apathy in Alzheimer’s disease

September 15, 2010  

Is there a role for statins in Alzheimer’s disease?

August 18, 2010  

FDG-PET useful in differential diagnosis of dementia

June 23, 2010  

Treatment effects in AD: overview of recent studies

June 23, 2010  

Selegiline less effective than levodopa, dopamine agonists: meta-analysis

April 28, 2010  
Previous
4
5
6
7
8
Next

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • AAN 2025 (5)
  • BIOMARKERS IN MS (54)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Treatment discontinuation in MS: the DOT-MS trial posted on May 5, 2025
  • AAN 2025 – report on fluid biomarkers in MS posted on April 22, 2025
  • McDonald criteria 2024: what changes can we expect? posted on January 30, 2024
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions